ClinConnect ClinConnect Logo
Search / Trial NCT06000449

Center M: Digital Health Innovation Pilot

Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · Aug 14, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Maternal Mental Health Telehealth

ClinConnect Summary

The Center M trial is studying a new digital health program designed to help women dealing with perinatal depression, which is depression that occurs during pregnancy or shortly after giving birth. This program offers an alternative to traditional therapy by using a smartphone app to provide support and resources, making it easier for participants to access help from home. The trial will compare this new digital approach with standard treatment options to see how effective it can be in improving mental health for pregnant women.

To be eligible for this trial, participants need to be women aged 18 to 50 who are currently pregnant and can speak English. They also need to be able to join online group meetings. However, those who have previously participated in similar mindfulness programs won't be able to join. If you take part in the trial, you can expect to use an app for your treatment, attend virtual group sessions, and receive digital materials to help you manage your symptoms. This study is currently recruiting participants, and it aims to find out if this innovative approach can make a difference in treating perinatal depression.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Currently pregnant
  • Age 18-50 years
  • Fluent in English
  • Available and able to attend online group scheduled meetings
  • Exclusion Criteria:
  • Current or past enrollment in a mindfulness-based intervention group

About Oregon Health And Science University

Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.

Locations

Portland, Oregon, United States

Patients applied

KR

1 patients applied

Trial Officials

Ellen Tilden, PhD, CNM, FACNM

Principal Investigator

Oregon Health and Science University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported